Depletion of CD4⁺ and CD8 ⁺ Cells Eliminates Immunologic Memory of Thyroiditogenicity in Murine Experimental Autoimmune Thyroiditis

References

• ElRehcwy M., Kong Y. M., Giraldo A. A., Rose N. R. Syngcncic thyroglobulin is immunogenic in good respondcr mice. Eur. J. Immunol 1981; 11: 146–151
   PubMedGoogle Scholar
• Rose N. R., Twarog F. J., Crowle A. J. Murine thyroiditis: importance of adjuvant and mouse strain for the induction of thyroid lesions. J. Immunol 1971; 106: 698–704
   PubMed Web of Science ®Google Scholar
• Esquivel P. S., Rose N. R., Kong Y. M. Induction of autoimmunity in good and poor responder mice with mouse thyroglobulin and lipopolysaccharide. J. Exp. Med 1977; 145: 1250–1263
   PubMed Web of Science ®Google Scholar
• Christadoss P., Kong Y. M., ElRehewy M., Rose N. R., David C. S. Genetic control of T‐lymphocyte proliferative autoimmune response to thyroglobulin in mice. Genetic Control of Autoimmune Disease, N. R. Rose, P. E. Bigazzi, N. L. Warner. Elsevier North Holland, New York 1978; 445–454
   Google Scholar
• Okayasu I., Kong Y. M., David C. S., Rose N. R. In vitro T‐lymphocyte proliferative response to mouse thyroglobulin in experimental autoimmune thyroiditis. Cell, Immunol 1981; 61: 32–39
   PubMedGoogle Scholar
• Simon L. L., Krco C. J., David C. S., Kong Y. M. Characterization of the in vitro murine T‐cell proliferative responses to murine and human thyroglobulins in thyroiditis‐susceptible and‐resistant mice. Cell. Immunol 1985; 94: 243–253
   PubMedGoogle Scholar
• Kong Y. M., Waldmann H., Cobbpld S., Giraldo A. A., Fuller B. E., Simon L. L. Pathogenic mechanisms in murine autoimmune thyroiditis: short‐and long‐term effects of in vivo depletion of CD4 + and CD8 + cells. Clin. Exp. Immunol 1989; 77: 428–433
   PubMedGoogle Scholar
• Simon L. L., Justen J. M., Giraldo A. A., Krco C. J., Kong Y. M. Activation of cytotoxic T cells and effector cells in experimental autoimmune thyroiditis by shared determinants of mouse and human thyroglobulins. Clin. Immunol. Immunopathol 1986; 39: 345–356
   PubMedGoogle Scholar
• Flynn J. C., Conaway D. H., Cobbold S., Waldmann H., Kong Y. M. Depletion of L3T4+ and Lyt‐2+ cells by rat monoclonal antibodies alters the development of adoptively transferred experimental autoimmune thyroiditis. Cell. Immunol 1989; 122: 377–390
   PubMed Web of Science ®Google Scholar
• Braley‐Mullen H., Johnson M., Sharp G. C., Kyriakos M. Induction of experimental autoimmune thyroiditis in mice with in vitro activated splenic T cells. Cell. Immunol 1985; 93: 132–143
   PubMed Web of Science ®Google Scholar
• Conaway D. H., Giraldo A. A., David C. S., Kong Y. M. In situ analysis of T cell subset composition in experimental autoimmune thyroiditis after adoptive transfer of activated spleen cells. Cell. Immunol 1990; 125: 247–253
   PubMedGoogle Scholar
• Creemers P., Rose N. R., Kong Y. M. Experimental autoimmune thyroiditis: in vitro cytotoxic effects of T lymphocytes on thyroid monolayers. J. Exp. Med 1983; 157: 559–571
   PubMedGoogle Scholar
• Salamcro J., Charreire J. Syngeneic sensitization of mouse lymphocytes on monolayers of thyroid epithelial cells. VII. Generation of thyroid‐specific cytotoxic effector cells. Cell. Immunol 1985; 91: 111–118
   PubMedGoogle Scholar
• Creemers P., Giraldo A. A., Rose N. R., Kong Y. M. T‐cell subsets in the thyroids of mice developing autoimmune thyroiditis. Cell. Immunol 1984; 87: 692–697
   PubMed Web of Science ®Google Scholar
• Conaway D. H., Giraldo A. A., David C. S., Kong Y. M. In situ kinetic analysis of thyroid lymphocyte infiltrate in mice developing experimental autoimmune thyroiditis. Clin. Immunol. Immunopathol 1989; 53: 346–353
   PubMedGoogle Scholar
• Kong Y. M., David C. S., Giraldo A. A., Irehewy E. M., Rose N. R. Regulation of autoimmune response to mouse thyroglobulin: influence of H‐2D‐end genes. J. Immunol 1979; 123: 15–18
   PubMed Web of Science ®Google Scholar
• Cobbold S. P., Jayasuriya A., Nash A., Prospero T. D., Waldmann H. Therapy with monoclonal antibodies by elimination of T‐cell subsets. in vivo. Nature 1984; 312: 548–551
   PubMed Web of Science ®Google Scholar
• Cobbold S. P., Martin G., Qin S., Waldmann H. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 1986; 323: 164–166
   PubMed Web of Science ®Google Scholar
• Qin S., Cobbold S., Tighe H., Benjamin R., Waldmann H. CD4 monoclonal antibody pairs for immunosuppression and tolerance induction. Eur. J. Immunol 1987; 17: 1159–1165
   PubMedGoogle Scholar
• Qin S., Cobbold S., Benjamin R., Waldmann H. Induction of classical transplantation tolerance in the adult. J. Exp. Med 1989; 169: 779–794
   PubMedGoogle Scholar
• Kong Y. M., Giraldo A. A., Waldmann H., Cobbold S. P., Fuller B. E. Resistance to experimental autoimmune thyroiditis: L3T4 + cells as mediators of both thyroglobulin‐activated and TSH‐induced suppression. Clin. Immunol. Immunopathol 1989; 51: 38–54
   PubMedGoogle Scholar
• Qin S., Wise M., Cobbold S. P., Leong L., Kong Y. M., Parnes J. R., Waldmann H. Induction of tolerance in peripheral T cells with monoclonal antibodies. Eur. J. Immunol 1990; 20: 2737–2745
   PubMed Web of Science ®Google Scholar
• Nabozny G. H., Cobbold S. P., Waldmann H., Kong Y. M. Suppression in murine experimental autoimmune thyroiditis: in vivo inhibition of CD4 + T cell‐mediated resistance by a nondepleting rat CD4 monoclonal antibody. Cell. Immunol 1991; 138: 185–196
   PubMedGoogle Scholar
• Hale G., Clark M., Waldmann H. Therapeutic potential of rat monoclonal antibodies: isotypc specificity of antibody‐dependent cell‐mediated cytotoxicity with human lymphocytes. J. Immunol 1985; 134: 3056–3060
   PubMedGoogle Scholar
• Lanier L. L., Gutman G. A., Lewis D. E., Griswold S. T., Warner N. L. Monoclonal antibodies against rat immunoglobulin kappa chains. Hybridoma 1982; 1: 125–131
   PubMedGoogle Scholar
• Aqcl N. M., Clark M., Cobbold S. P., Waldmann H. Immunohistological screening in the selection of monoclonal antibodies: the use of isotype‐specific antiglobulins. J. Immunol. Methods 1984; 69: 207–214
   PubMedGoogle Scholar
• Poston R. N. A buffered chromic chloride method of attaching antigens to red cells: use in haemagglutination. J. Immunol. Methods 1974; 5: 91–96
   PubMedGoogle Scholar
• Stull S. J., Kyriakos M., Sharp G. C., Braley‐Mullen H. Prevention and reversal of experimental autoimmune thyroiditis (EAT) in mice by administration of anti‐L3T4 monoclonal antibody at different stages of disease development. Cell. Immunol 1988; 117: 188–198
   PubMedGoogle Scholar
• Sriram S., Roberts C. A. Treatment of established chronic relapsing experimental allergic encephalomyelitis with anti‐L3T4 antibodies. J Immunol 1986; 136: 4464–4469
   PubMed Web of Science ®Google Scholar
• Waldor M. K., Sriram S., Hardy R., Hcrzcnberg L. A., Hcrzcnberg L. A., Lanier L., Lim M., Steinman L. Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T‐cell subset marker. Science 1985; 227: 415–417
   PubMed Web of Science ®Google Scholar
• Ranges G. E., Sriram S., Cooper S. M. Prevention of type II collagen‐induced arthritis by in vivo treatment with anti‐L3T4. J. Exp. Med 1985; 162: 1105–1110
   PubMed Web of Science ®Google Scholar
• Kantwerk G., Cobbold S., Waldmann H., Kolb H. L3T4 and Lyt‐2 T cells are both involved in the generation of low‐dose streptozotocin‐induced diabetes in mice. Clin. Exp. Immunol 1987; 70: 585–592
   PubMedGoogle Scholar
• Koike T., Itoh Y., Ishii T., Ito I., Takabayashi K., Maruyama N., Tomioka H., Yoshida S. Preventive effect of monoclonal anti‐L3T4 antibody on development of diabetes in NOD mice. Diabetes 1987; 36: 539–541
   PubMed Web of Science ®Google Scholar
• Shizuru J. A., Taylor‐Edwards C., Banks B. A., Gregory A. K., Fathman C. G. Immunotherapy of the nonobese diabetic mouse: treatment with an antibody to T‐helper lymphocytes. Science 1988; 240: 659–662
   PubMed Web of Science ®Google Scholar
• Benjamin R. J., Waldmann H. Induction of tolerance by monoclonal antibody therapy. Nature 1986; 320: 449–451
   PubMed Web of Science ®Google Scholar
• Benjamin R. J., Qin S., Wise M. P., Cobbold S. P., Waldmann H. Mechanisms of monclonal antibody‐facilitated tolerance induction: a possible role for the CD4 (L3T4) and CD11a (LFA‐1) molecules in self‐non‐self discrimination. Eur. J. Immunol 1988; 18: 1079–1088
   PubMed Web of Science ®Google Scholar
• Gutstein N. L., Seaman W. E., Scott J. H., Wofsy D. Induction of immune tolerance by administration of monoclonal antibody to L3T4. J. ImmunoL 1986; 137: 1127–1132
   PubMedGoogle Scholar
• Benjamin R. J., Cobbold S. P., Clark M. R., Waldmann H. Tolerance to rat monoclonal antibodies: implications for serotherapy. J. Exp. Med 1986; 163: 1539–1552
   PubMed Web of Science ®Google Scholar
• Fuller B. E., Okayasu I., Simon L. L., Giraldo A. A., Kong Y. M. Characterization of resistance to murine experimental autoimmune thyroiditis: duration and afferent action of thyroglobulin‐and TSH‐induced suppression. Clin. Immunol. Immunopathol 1993; 69: 60–68
   PubMedGoogle Scholar
• Hutchings P. R., Cooke A., Dawe K., Waldmann H., Roitt I. M. Active suppression induced by anti‐CD4. Eur. J. Immunol 1993; 23: 965–968
   PubMed Web of Science ®Google Scholar
• Okayasu I., Hatakeyama S., Kong Y. M. Long‐term observation and effect of age on induction of experimental autoimmune thyroiditis in susceptible and resistant mice. Clin. Immunol. Immunopathol 1989; 53: 254–267
   PubMedGoogle Scholar